Navigation Links
Amicus Therapeutics Announces Change to Board of Directors
Date:2/18/2009

CRANBURY, N.J., Feb. 18 /PRNewswire-FirstCall/ -- Amicus Therapeutics (Nasdaq: FOLD) announced today that Stephen Bloch, M.D., General Partner with Canaan Equity Partners, has resigned from the Company's Board of Directors effective February 17, 2009. Dr. Bloch served as a member of Amicus' board since 2004.

About Amicus Therapeutics

Amicus Therapeutics is a biopharmaceutical company developing novel, oral therapeutics known as pharmacological chaperones for the treatment of a range of human genetic diseases. Pharmacological chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with unmet medical needs. Amicus has completed Phase 2 clinical trials of Amigal for the treatment of Fabry disease and is conducting Phase 2 clinical trials of Plicera for the treatment of Gaucher disease and AT2220 for the treatment of Pompe disease.

FOLD-G


'/>"/>
SOURCE Amicus Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Amicus Therapeutics Announces Fourth Quarter and Full Year 2008 Financial Results
2. Amicus Therapeutics Announces Fourth Quarter and Year End 2008 Financial Results Release Date
3. Amicus Therapeutics Adds Sol J. Barer, Ph.D. to Board of Directors
4. Amicus Therapeutics to Present at Lazard Capital Markets Healthcare Conference
5. Amicus Therapeutics Announces Third Quarter 2008 Financial Results
6. Amicus Therapeutics Announces Third Quarter 2008 Results Release Date
7. Amicus Therapeutics to Present at the 2008 UBS Global Life Sciences Conference
8. Amicus Therapeutics Opens Research Facility in San Diego
9. Amicus Therapeutics to Present at the 2008 BioCentury NewsMakers in the Biotech Industry Conference
10. Amicus Therapeutics Announces Second Quarter 2008 Results Release Date
11. Amicus Therapeutics Announces First Quarter 2008 Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/7/2009)...wire/ -- Research projects in the areas of mathema...g, as Tim Kunisky of Livingston, NJ and the team o...A received the highest honors at the Region Five F...ence & Technology, the nation,s premier high s...scom.com/cgi-bin/prnh/20070904/SIEMENSLOGO ) ,...
(Date:11/6/2009)...Call/ - Microbix Biosystems Inc. (the "Company") a...9F1 Certification of Annual Filings of William Gas...he Chief Financial Officer (the "Officer,s Certifi...the annual audited financial statements for the ye...tially filed the annual financial statements for t...
(Date:11/6/2009)...e-FirstCall/ -- BioSpecifics Technologies Corp. (N...ping first-in-class collagenase-based products, to...quarter ended September 30, 2009. ,, "We were ...he FDA,s Arthritis Advisory Committee unanimously ...AFLEX(TM) for the treatment of Dupuytren,s disease...
(Date:11/6/2009)...re-FirstCall/ -- Helix BioPharma Corp. (TSX, FSE: ...ohn Docherty, president and chief operating office...al Investor Summit on November 10, 2009 at 4:00 PM...rty will provide an overview of the Company,s lead...al Interferon Alpha-2b. The slide show portion of...
Breaking Biology Technology:Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 2Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 3Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 4Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 5Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 6Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 6Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 3
...s New Opportunity to Serve Pharmaceutical Partner ...s in China, OMAHA, Neb., March 31 Transgenomic, ...analysis and services company,today announced that...nt,with the Guangzhou Family Planning Center in Gu... will partner with the Guangzhou Laboratory to,pro...
... Have the Guts?, aims to reach five million in fiv...cs,Incorporated (NYSE: DGX ), the nation,s leadin...ervices, today announced the launch of a novel,cam...ke-home colorectal,screening tests. Titled "It,s T...s?," the campaign aims to break down barriers to c...
...nce Call To Be Held Tuesday, April 1, 2008 At 10:0...t Time, HOPKINTON, Mass., March 31 Alseres,Pharm...onsolidated financial,results for the year ended D... http://www.newscom.com/cgi-bin/prnh/20070608/NEF0...al, regulatory, pipeline and,business accomplishme...
Other Biology Technology:Transgenomic Opens Pharmacogenomics Laboratory in China 2Transgenomic Opens Pharmacogenomics Laboratory in China 3Quest Diagnostics Campaign Challenges Colorectal Cancer Screening Status Quo 2Quest Diagnostics Campaign Challenges Colorectal Cancer Screening Status Quo 3Quest Diagnostics Campaign Challenges Colorectal Cancer Screening Status Quo 4Alseres Pharmaceuticals, Inc. Reports 2007 Financial Results and Provides Company Highlights 2Alseres Pharmaceuticals, Inc. Reports 2007 Financial Results and Provides Company Highlights 3Alseres Pharmaceuticals, Inc. Reports 2007 Financial Results and Provides Company Highlights 4Alseres Pharmaceuticals, Inc. Reports 2007 Financial Results and Provides Company Highlights 5Alseres Pharmaceuticals, Inc. Reports 2007 Financial Results and Provides Company Highlights 6Alseres Pharmaceuticals, Inc. Reports 2007 Financial Results and Provides Company Highlights 7Alseres Pharmaceuticals, Inc. Reports 2007 Financial Results and Provides Company Highlights 8Alseres Pharmaceuticals, Inc. Reports 2007 Financial Results and Provides Company Highlights 9Alseres Pharmaceuticals, Inc. Reports 2007 Financial Results and Provides Company Highlights 10
(Date:11/3/2009)...009) For more than 25 years, all attempts at cult... ) have been unsuccessfuluntil now. For the first ...produce beaded (nucleated) and non-beaded cultured...y scientists from Florida Atlantic University,s Ha...ess than two years of research and experimentation...
(Date:11/3/2009)...ort published in a recent issue of HortTechnology...ned the effects of covering orchard floors with re...py light distribution, orchard temperature, and pr...Extenday and Solarmate films installed 5 weeks bef...a, apples. The research showed that the use of bot...
(Date:11/3/2009)...re as much as 28 percent less likely to become pre...o research that earned a Michigan State University...arbara Luke, a researcher in the MSU College of Hu...y and Reproductive Biology, focused on data of nea...ology. , Luke,s findings, which also can be appl...
Breaking Biology News(10 mins):Scientists are first to 'unlock' the mystery of creating cultured pearls from the queen conch 2Scientists are first to 'unlock' the mystery of creating cultured pearls from the queen conch 3Reflective film can boost profits for apple growers 2MSU researcher: Obesity significantly cuts odds of successful pregnancy 2Health Care Company Donates 2460 000 to Keep Community Pool Open 49945 1Health Care Company Donates 2460 000 to Keep Community Pool Open 49945 2Physician Wellness Services Names Alan Rosenstein M D M B A as Medical Director 49941 1Physician Wellness Services Names Alan Rosenstein M D M B A as Medical Director 49941 2Physician Wellness Services Names Alan Rosenstein M D M B A as Medical Director 49941 3International Products Corp s Lab Offers Filter Membrane Compatibility and Studies 12770 1International Products Corp s Lab Offers Filter Membrane Compatibility and Studies 12770 2
... outbreak of the phenomenon commonly called "red t...ing and summer, according to researchers with the ...rth Carolina State University (NCSU). , This adv...ey of quantities of Alexandrium fundyense the...lates in clams, mussels, and other shellfish and c...
...(EMBARGOED UNTIL WEDNESDAY, APRIL 22, 2009; 2:00 A... International Development (USAID) and the Wildlif...,s National Environment Protection Agency (NEPA), ...ntry,s first internationally recognized national p...park,s creation, including support of WCS to condu...
... of 2006 and 2007, an international team of resear... treasure trove of dinosaur skeletons from Early C...esert near the ancient Silk Road city of Jiayuguan...represent new species of theropod dinosaurs, and b...hed on-line in the Proceedings of the Royal Socie...
Other Biology News:Researchers report 'moderately large' potential for red tide outbreak in Gulf of Maine region 2Researchers report 'moderately large' potential for red tide outbreak in Gulf of Maine region 3Researchers report 'moderately large' potential for red tide outbreak in Gulf of Maine region 4Afghanistan declares its first national park 2Field Museum paleontologist leads study on two new dinosaurs from China 2Field Museum paleontologist leads study on two new dinosaurs from China 3Field Museum paleontologist leads study on two new dinosaurs from China 4
...I from vaccinia virus is a type I eukaryotic topoi...uperhelical turns (also called right- and left-han...oduct of the reaction is a covalently closed, circ...cal turns. DNA Topoisomerase I does not absolutely...
Eco RII (Bst NI) from Roche Applied Science
...I from vaccinia virus is a type I eukaryotic topoi...uperhelical turns (also called right- and left-han...oduct of the reaction is a covalently closed, circ...cal turns. DNA Topoisomerase I does not absolutely...
...etase Activity Kit ADAM17 Activity Kit TNF-α...T FROM LIGHT. AVOID FREEZE/THAW CYCLES. The InnoZy...itive assay designed to measure human TACE activit...creening enzyme inhibitors. An Anti-Human TACE-Coa...
Biology Products: